Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Barrett's esophagus: the changing management

G R Lichtenstein1, G W Crooks

  • 1Department of Medicine, University of Pennsylvania School of Medicine, Philadelphia, USA.

Hospital Practice (1995)
|December 31, 1997
PubMed
Summary

Gastroesophageal reflux may lead to a serious disease affecting 700,000 Americans. Management decisions involve determining which patients need endoscopic surveillance versus medical or surgical therapy.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Major Trends in Gastroenterology and Hepatology Between 2010 and 2019: An Overview of Advances From the Past Decade Selected by the Editorial Board of The American Journal of Gastroenterology.

The American journal of gastroenterology·2020
Same author

Long-term safety and efficacy of certolizumab pegol in the treatment of Crohn's disease: 7-year results from the PRECiSE 3 study.

Alimentary pharmacology & therapeutics·2014
Same author

Increased expression of interleukin-8 mRNA in ulcerative colitis and Crohn's disease mucosa and epithelial cells.

Inflammatory bowel diseases·2013
Same author

Mesalazine granules 1.5 g once-daily maintain remission in patients with ulcerative colitis who switch from other 5-ASA formulations: a pooled analysis from two randomised controlled trials.

Alimentary pharmacology & therapeutics·2012
Same author

Early symptomatic response and mucosal healing with mesalazine rectal suspension therapy in active distal ulcerative colitis--additional results from two controlled studies.

Alimentary pharmacology & therapeutics·2011
Same author

Review article: delivery and efficacy of topical 5-aminosalicylic acid (mesalazine) therapy in the treatment of ulcerative colitis.

Alimentary pharmacology & therapeutics·2011

Area of Science:

  • Gastroenterology and Oncology

Background:

  • Gastroesophageal reflux disease (GERD) is a common condition.
  • A subset of patients with GERD may progress to adenocarcinoma.
  • The prevalence of this condition in the US is estimated at 700,000 individuals.

Observation:

  • The disease is often preceded by gastroesophageal reflux.
  • Progression to adenocarcinoma is a known risk.
  • Key management questions involve surveillance and treatment strategies.

Findings:

  • Identifying patients who require endoscopic surveillance is crucial.
  • Determining the appropriateness of medical therapy versus surgical intervention is a management challenge.

Implications:

  • Optimizing surveillance protocols can lead to earlier detection of precancerous conditions.
  • Tailored treatment strategies, including medical and surgical options, are essential for effective patient management.
  • Further research is needed to refine diagnostic and therapeutic guidelines for this patient population.

Related Experiment Videos